Approval · Notice of Compliance 10783 · 2009
TROSEC: Notice of Compliance 10783
Issued November 13, 2009
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 10783
- Date
- November 13, 2009
- Company
- Sepracor Pharmaceuticals IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Antispasmodic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TROSEC | 02275066 | Cancelled Post Market |
Medicinal ingredients
- TROSPIUM CHLORIDE 20 MG per TAB